MyFinsight
Home
Blog
About
Proprietary Products
$722,600K
(16.59%↑ Y/Y)
West Vantage Segment
$149,700K
Net sales
$872,300K
(13.80%↑ Y/Y)
Gross profit
$329,200K
(20.19%↑ Y/Y)
Cost of goods and
services sold
$543,100K
(10.25%↑ Y/Y)
Operating profit
$179,100K
(16.53%↑ Y/Y)
Interest income
$3,800K
(5.56%↑ Y/Y)
Selling, general and
administrative expenses
$117,600K
(22.63%↑ Y/Y)
Research and development
$19,700K
(3.14%↑ Y/Y)
Other expense
(income) (note 14)
-$12,800K
(-146.15%↓ Y/Y)
Income before income
taxes and equity in net...
$180,100K
(14.71%↑ Y/Y)
Equity in net income of
affiliated companies
$6,100K
(22.00%↑ Y/Y)
Interest expense, net
$2,600K
(2500.00%↑ Y/Y)
Other nonoperating
expense (income)
-$200K
(0.00%↑ Y/Y)
Net income
$154,000K
(16.84%↑ Y/Y)
Income tax expense
$32,200K
(6.62%↑ Y/Y)
Back
Back
Income Statement
West_Pharmaceutical_Services_Logo-svg
WEST PHARMACEUTICAL SERVICES INC (WST)
West_Pharmaceutical_Services_Logo-svg
source: myfinsight.com
WEST PHARMACEUTICAL SERVICES INC (WST)